BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ziegler V, Deußen M, Schumacher L, Roos WP, Fritz G. Anticancer drug and ionizing radiation-induced DNA damage differently influences transcription activity and DDR-related stress responses of an endothelial monolayer. Biochim Biophys Acta Mol Cell Res 2020;1867:118678. [PMID: 32061892 DOI: 10.1016/j.bbamcr.2020.118678] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Brinkmann V, Fritz G. Prevention of anticancer therapy-induced neurotoxicity: putting DNA damage in perspective. Neurotoxicology 2022:S0161-813X(22)00057-2. [PMID: 35487345 DOI: 10.1016/j.neuro.2022.04.009] [Reference Citation Analysis]
2 Xiao X, Zhang Z, Xie H, Li S, Li J. Bone Marrow Mesenchymal Stem Cells Derived Discoidin Domain-Containing Receptor 2 (DDR2) as a Communication Mediator to Strengthen the Invasiveness and Metastasis of Papillary Thyroid Carcinoma. j biomater tissue eng 2022;12:514-22. [DOI: 10.1166/jbt.2022.2937] [Reference Citation Analysis]
3 Niwa Y, Kamimura K, Ogawa K, Oda C, Tanaka Y, Horigome R, Ohtsuka M, Miura H, Fujisawa K, Yamamoto N, Takami T, Okuda S, Ko M, Owaki T, Kimura A, Shibata O, Morita S, Sakai N, Abe H, Yokoo T, Sakamaki A, Kamimura H, Terai S. Cyclin D1 Binding Protein 1 Responds to DNA Damage through the ATM–CHK2 Pathway. JCM 2022;11:851. [DOI: 10.3390/jcm11030851] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Lin F, Tang YD, Zheng C. The crosstalk between DNA damage response components and DNA-sensing innate immune signaling pathways. Int Rev Immunol 2021;:1-9. [PMID: 33749478 DOI: 10.1080/08830185.2021.1898605] [Reference Citation Analysis]
5 Possenti L, Mecchi L, Rossoni A, Sangalli V, Bersini S, Cicchetti A, Costantino ML, Candrian C, Arrigoni C, Rancati T, Moretti M. Radiobiological Studies of Microvascular Damage through In Vitro Models: A Methodological Perspective. Cancers (Basel) 2021;13:1182. [PMID: 33803333 DOI: 10.3390/cancers13051182] [Reference Citation Analysis]